WASHINGTON. AT A GLANCE.

Headline metadata snapshot

Observed version 1

FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

Captured

Original source

FieldPreviousThis version
title—FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
published raw—Tue, 10 Nov 2026 14:43:49 +0000
updated raw——
url—https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns/
source name—Ars Technica
Integrity fingerprint6280f9d83e6a68837c5f57f15c87f7bb4ef7dbc86586d24c77086d7a32e554ef

Headline metadata only; article body not captured. Observation time is not the publisher’s edit time.

Full observed history